Performance of Afirma genomic sequencing classifier vs gene expression classifier in Bethesda category III thyroid nodules: An institutional experience.
Lin ZhangBrian SmolaMadelyn LewJudy PangRichard L CantleyLiron PantanowitzAmer HeiderXin JingPublished in: Diagnostic cytopathology (2021)
Afirma GSC substantially improved BCR, RSS, RHM, and diagnostic performance, enhancing appropriate triage and thereby helped avoid unnecessary surgery in AUS/FLUS thyroid nodules.